{"id":"W4283798787","doi":"10.1053/j.gastro.2022.06.068","title":"CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease","year":2022,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; University of Toronto; Mount Sinai Hospital; St. Paul's Hospital; University of Calgary; McGill University; University of British Columbia; University of Manitoba","funders":"Canadian Institutes of Health Research; Takeda Canada; Pfizer Canada; Shire; Genentech; Prometheus Biosciences; Bristol-Myers Squibb Canada; Protagonist Therapeutics; Janssen Pharmaceuticals; Gilead Sciences; AbbVie Canada; Seres Therapeutics; Janssen Canada; Amgen Canada; Sanofi; Roche; GlaxoSmithKline; Pfizer","keywords":"Medicine; Calprotectin; Randomized controlled trial; Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; Clinical trial; Internal medicine; Clinical endpoint; Multidisciplinary approach; Delphi method; Outcomes research; Patient-reported outcome; Disease; Physical therapy; Quality of life (healthcare); Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5210611,0.005654166,0.02865011,0.01533418,0.005265281,0.01481268,0.01389517,0.0123968,0.005784273],"category_scores_gemma":[0.5276951,0.003845525,0.0244275,0.01200563,0.005041284,0.007480741,0.02217839,0.02301638,0.002906713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01704891,"about_ca_system_score_gemma":0.06879652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006300339,"about_ca_topic_score_gemma":0.008919848,"domain_scores_codex":[0.525961,0.2729501,0.1301807,0.009464391,0.05545588,0.005987856],"domain_scores_gemma":[0.3554225,0.4069625,0.07515392,0.03444485,0.1042298,0.0237864],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.02231914,0.001181499,0.01184034,0.1837893,0.05603604,0.0003891566,0.002551206,0.01055538,0.003835267,0.04976508,0.1401065,0.5176311],"study_design_scores_gemma":[0.07218907,0.004597636,0.04949237,0.3066888,0.08209328,0.001060129,0.001371656,0.02342697,0.006407164,0.09825229,0.3533274,0.001093325],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.01706714,0.1720007,0.4198201,0.1105595,0.01508426,0.2072586,0.02977789,0.005501966,0.02292988],"genre_scores_gemma":[0.03950419,0.02299283,0.7283511,0.0231624,0.002355896,0.1605551,0.02014922,0.001274799,0.001654509],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.4789389,"threshold_uncertainty_score":0.5906169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.063015279466745,"score_gpt":0.3478573483873491,"score_spread":0.284842068920604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}